We invest in Therapeutics,
MedTech and
Digital Health
Bionova Capital is an independent, healthcare-specialized venture capital firm, having been investing in early-stage life science companies since 2015. Bionova Capital invests in groundbreaking therapeutics, medtech and digital health startups across Europe.
Know more
Portfolio
Bionova Capital works closely with entrepreneurs to build leading companies with technologies and products transforming people’s health. We invest in seed rounds and typically bring additional investors to our portfolio companies to add value and mitigate risk. Learn more about our current portfolio across Europe.
Know more
.jpg)
Our Network
We have developed a wide network across Europe that includes research institutes, incubators and accelerators. Through this network, we have access to a rich pipeline of potential investments.
Our Partners
Latest News
Biovance Capital Partners, a new venture capital company is launched by Bionova Capital’s team
Biovance Capital Partners is set to manage a new fund up to € 60 million supported by the European Investment Fund (EIF) to invest in early-stage biotech companies across Europe.
Bionova Capital’s portfolio company Delox secures € 750,000
Delox raises new investment to launch breakthrough antimicrobial system.
Bionova Capital’s portfolio company Adapttech raises £2.3 million and launches new prosthetic-fitting technologies
Adapttech secures new investment to grow global sales and expand its product range to improve fitting of lower-limb protheses